Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.dsx.2021.102189 http://scihub22266oqcxt.onion/10.1016/j.dsx.2021.102189 34217144!8236412!34217144     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34217144&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Diabetes+Metab+Syndr 2021 ; 15 (4): 102189 Nephropedia Template TP {{tp|p=34217144|t=2021. "Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis" |pdf=|usr=}}{{34217144}} gab.com Text "Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis" JO: Diabetes Metab Syndr http://www.kidney.de/pget.php?&tw=1&pmid=34217144 #FOAvip BACKGROUND: Vitamin-D is an immune-modulator which might be linked to disease severity by SARS-CoV-2. METHODS: Meta-analysis of RCTs and quasi-experimental studies, evaluating the role of vitamin-D supplementation in COVID patients was done. RESULTS: Total 5 studies (3 RCTs and 2 Quasi-experimental) including n = 467 patients were included. Vitamin D didn't reduce mortality (RR 0.55, 95%CI 0.22 to 1.39, p = 0.21), ICU admission rates (RR 0.20, 95% CI 0.01-4.26, p = 0.3) and need for invasive ventilation (RR 0.24, 95% CI 0.01-7.89, p = 0.42). CONCLUSION: No significant difference with vitamin-D supplementation on major health related outcomes in COVID-19. Well-designed RCTs are required addressing this topic. Twit Text FOAVip "Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis" ????Diabetes Metab Syndr http://www.kidney.de/pget.php?&tw=1&pmid=34217144 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34217144 #FOAvip English Wikipedia <ref>{{Cite pmid|34217144}}</ref> "Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis" #MMPMID34217144 Rawat D; Roy A; Maitra S; Shankar V; Khanna P; Baidya DK Diabetes Metab Syndr 2021[Jul]; 15 (4): 102189 PMID34217144show ga BACKGROUND: Vitamin-D is an immune-modulator which might be linked to disease severity by SARS-CoV-2. METHODS: Meta-analysis of RCTs and quasi-experimental studies, evaluating the role of vitamin-D supplementation in COVID patients was done. RESULTS: Total 5 studies (3 RCTs and 2 Quasi-experimental) including n = 467 patients were included. Vitamin D didn't reduce mortality (RR 0.55, 95%CI 0.22 to 1.39, p = 0.21), ICU admission rates (RR 0.20, 95% CI 0.01-4.26, p = 0.3) and need for invasive ventilation (RR 0.24, 95% CI 0.01-7.89, p = 0.42). CONCLUSION: No significant difference with vitamin-D supplementation on major health related outcomes in COVID-19. Well-designed RCTs are required addressing this topic. |*COVID-19 Drug Treatment[MESH] |*Dietary Supplements[MESH] |COVID-19/epidemiology/virology[MESH] |Humans[MESH] |Nutrition Therapy/*methods[MESH] |Prognosis[MESH] |SARS-CoV-2/*drug effects[MESH] |Vitamin D/*administration & dosage[MESH]"Vitamin D supplementation and COVID-19 treatment: A systematic review(epmc).pdf DeepDyve Pubget Overpricing